Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI)
Clinical trial NCT02819479 · COMPLETED
Trial details
- NCT number
- NCT02819479
- Sponsor
- Norton Healthcare
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-23
- Primary completion
- 2019-06-06
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.